Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009.
Co-infection with seasonal influenza A (H1N1) and pandemic (H1N1) 2009 could result in reassortant viruses that may acquire new characteristics of transmission, virulence, and oseltamivir susceptibility. Results from oseltamivir-sensitivity testing on viral culture suggested the possibility of co-infections with oseltamivir-resistant (seasonal A [H1N1]) and -susceptible (pandemic [H1N1] 2009) viruses.
Peacey
Matthew
M
The Institute of Environmental Science and Research, National Centre for Biosecurity and Infectious Disease, Upper Hutt, New Zealand. mathew.peacey@esr.cri.nz
Hall
Richard J
RJ
Sonnberg
Stephanie
S
Ducatez
Mariette
M
Paine
Shevaun
S
Nicol
Mackenzie
M
Ralston
Jacqui C
JC
Bandaranayake
Don
D
Hope
Virginia
V
Webby
Richard J
RJ
Huang
Sue
S
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000494:pharmacology; D002648:Child; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000145:classification* / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D007251:Influenza, Human / Q000453:epidemiology / Q000821:virology; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D053139:Oseltamivir / Q000494:pharmacology; D058873:Pandemics; D012621:Seasons; D014776:Virus Cultivation; D055815:Young Adult
D000998:Antiviral Agents; D053139:Oseltamivir